Cite
MLA Citation
Charles C Wykoff et al.. “Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.” Lancet, vol. 399, no. 10326, 2022, pp. 741–755. http://access.bl.uk/ark:/81055/vdc_100152256346.0x000052